Scientists probe mitochondria to unlock depression treatment secrets
NCT ID NCT07399756
First seen Feb 21, 2026 · Last updated May 22, 2026 · Updated 7 times
Summary
This study looks at how S-ketamine, a fast-acting antidepressant, affects tiny energy-producing parts of cells called mitochondria in people with treatment-resistant depression. Researchers will take blood samples before, shortly after, and six weeks after treatment to see if changes in mitochondrial markers can predict who will respond well. The goal is to better understand how the drug works and find simple blood tests to guide treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MAJOR DEPRESSIVE DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Sheba Medical Center
Ramat Gan, Israel, 52621, Israel
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.